<DOC>
	<DOC>NCT01876563</DOC>
	<brief_summary>The aim of this study is the comparision between the effects of vitamin D or placebo supplementation for 2 months in serum level of thioredoxin, TBP-2 and thioredoxin reductase activity in patients with type 2 diabetes</brief_summary>
	<brief_title>the Effect of Vitamin D on the Serum Thioredoxin, TBP-2, Thioredoxin Reductase, Gene Expression of TBP-2 in Patients With Type II Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>literate, willingness to participation, diabetic patients 30 60 years old, body mass index in the range 18.5 35, avoidance of dietary supplements, vitamins and herbal products at least 3 months before and throughout the intervention people who have used vitamin D supplements in last 3 months, having chronic renal disease , GI disease, Hepatobilliary diseases, hematological disorders, hypo or hyperthyroidism, treatment with orlistat or sibutramine for weight loss, pregnancy and lactation, treatment with insulin or Thiazolidinediones, Smokers</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>thioredoxin</keyword>
	<keyword>TBP-2</keyword>
	<keyword>thioredoxin reductase</keyword>
	<keyword>vitamin D</keyword>
	<keyword>DIABETES</keyword>
</DOC>